-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Reiterates Overweight on Vericel, Maintains $67 Price Target

Benzinga·06/16/2025 14:41:30
Listen to the news
Stephens & Co. analyst Mason Carrico reiterates Vericel (NASDAQ:VCEL) with a Overweight and maintains $67 price target.